North America Opioid Induced Constipation (Oic) Drug Market Forecast 2017-2025
KEY FINDINGS The North America opioid-induced constipation drug market is expected to command the global OIC drug market during the forecast period of 2017-2025 with an expected CAGR growth of 5.65%. The revenue generated by the market is expected to increase from $2125 million in 2016 and reach $3551 million by 2025.
MARKET INSIGHTS The North American OIC drug market is segmented on the basis of the type of prescription and the type of drug. The prescription type market is further divided into prescribed drugs such as branded and generic drugs and the over the counter drugs which do not require any doctor prescription. The market on the type of drug can be further segmented into methyl naltrexone bromide, lubiprostone, naloxegol and pipeline drugs. The increase in healthcare spending, technological advancement in cardiology and growing lifestyle oriented diseases are aiding in the expansion of the market in this region.
COMPETITIVE INSIGHTS Some of the leading players in the market include Pfizer, Ironwood Pharmaceuticals Inc, Allergan PLC, Progenics Pharmaceuticals Inc, and others.